The involvement of regulatory non-coding RNAs in sepsis: a systematic review

Jeffery Ho, Hung Chan, Sunny H. Wong*, Maggie H. T. Wang, Jun Yu, Zhangang Xiao, Xiaodong Liu, Gordon Choi, Czarina C. H. Leung, Wai T. Wong, Zheng Li, Tony Gin, Matthew T. V. Chan*, William K. K. Wu*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

82 Citations (Scopus)
11 Downloads (CityUHK Scholars)

Abstract

Background: Sepsis coincides with altered gene expression in different tissues. Accumulating evidence has suggested that microRNAs, long non-coding RNAs, and circular RNAs are important molecules involved in the crosstalk with various pathways pertinent to innate immunity, mitochondrial functions, and apoptosis.

Methods: We searched articles indexed in PubMed (MEDLINE), EMBASE and Europe PubMed Central databases using the Medical Subject Heading (MeSH) or Title/Abstract words ("microRNA", "long non-coding RNA", "circular RNA", "sepsis" and/or "septic shock") from inception to Sep 2016. Studies investigating the role of host-derived microRNA, long non-coding RNA, and circular RNA in the pathogenesis of and as biomarkers or therapeutics in sepsis were included. Data were extracted in terms of the role of non-coding RNAs in pathogenesis, and their applicability for use as biomarkers or therapeutics in sepsis. Two independent researchers assessed the quality of studies using a modified guideline from the Systematic Review Center for Laboratory animal Experimentation (SYRCLE), a tool based on the Cochrane Collaboration Risk of Bias tool.

Results: Observational studies revealed dysregulation of non-coding RNAs in septic patients. Experimental studies confirmed their crosstalk with JNK/NF-kappa B and other cellular pathways pertinent to innate immunity, mitochondrial function, and apoptosis. Of the included studies, the SYRCLE scores ranged from 3 to 7 (average score of 4.55). This suggests a moderate risk of bias. Of the 10 articles investigating non-coding RNAs as biomarkers, none of them included a validation cohort. Selective reporting of sensitivity, specificity, and receiver operating curve was common.

Conclusions: Although non-coding RNAs appear to be good candidates as biomarkers and therapeutics for sepsis, their differential expression across tissues complicated the process. Further investigation on organ-specific delivery of these regulatory molecules may be useful.
Original languageEnglish
Article number383
Number of pages12
JournalCritical Care
Volume20
Online published28 Nov 2016
DOIs
Publication statusPublished - 2016
Externally publishedYes

Funding

This work was supported by the Hong Kong Research Grant Council-General Research Fund (464212, 24115815) and the Food and Health Bureau-Commissioned Research on Control of Infectious Diseases (CU-15-B2) and Health and Medical Research Fund (15140132).

Research Keywords

  • Sepsis
  • microRNA
  • lncRNA
  • circRNA
  • Biomarker
  • Inflammation
  • Shock
  • NF-KAPPA-B
  • RESPIRATORY-DISTRESS-SYNDROME
  • INTERNATIONAL CONSENSUS DEFINITIONS
  • INFLAMMATORY RESPONSE SYNDROME
  • TNF-ALPHA PRODUCTION
  • ACUTE LUNG INJURY
  • MICRORNA EXPRESSION
  • GENE-EXPRESSION
  • DOWN-REGULATION
  • CARDIAC DYSFUNCTION

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'The involvement of regulatory non-coding RNAs in sepsis: a systematic review'. Together they form a unique fingerprint.

Cite this